Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19: S-Peptide RBD 484-508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients.
Murdocca M, Citro G, Centanini E, Giannini R, Latini A, Centofanti F, Piano Mortari E, Cocciadiferro D, Novelli A, Bernardini S, Novelli G, Sangiuolo F. Murdocca M, et al. Among authors: bernardini s. Viruses. 2023 Jun 22;15(7):1417. doi: 10.3390/v15071417. Viruses. 2023. PMID: 37515105 Free PMC article.
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
Minutolo A, Petrone V, Fanelli M, Maracchioni C, Giudice M, Teti E, Coppola L, Sorace C, Iannetta M, Tony Miele M, Bernardini S, Mastino A, Sinibaldi Vallebona P, Balestrieri E, Andreoni M, Sarmati L, Grelli S, Garaci E, Matteucci C. Minutolo A, et al. Among authors: bernardini s. Int Immunopharmacol. 2023 May;118:110055. doi: 10.1016/j.intimp.2023.110055. Epub 2023 Mar 22. Int Immunopharmacol. 2023. PMID: 36989892 Free PMC article.
Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.
Younes S, Nicolai E, Pieri M, Bernardini S, Daas HI, Al-Sadeq DW, Younes N, Shurrab FM, Nizamuddin PB, Humaira F, Al-Dewik N, Yassine HM, Abu-Raddad LJ, Ismail A, Nasrallah GK. Younes S, et al. Among authors: bernardini s. Influenza Other Respir Viruses. 2024 May;18(5):e13290. doi: 10.1111/irv.13290. Influenza Other Respir Viruses. 2024. PMID: 38706402 Free PMC article.
The Antibodies' Response to SARS-CoV-2 Vaccination: 1-Year Follow Up.
Nicolai E, Tomassetti F, Pelagalli M, Sarubbi S, Minieri M, Nisini A, Nuccetelli M, Ciotti M, Pieri M, Bernardini S. Nicolai E, et al. Among authors: bernardini s. Biomedicines. 2023 Sep 28;11(10):2661. doi: 10.3390/biomedicines11102661. Biomedicines. 2023. PMID: 37893035 Free PMC article.
SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Zedan HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, Nicolai E, Pieri M, Bernardini S, Hssain AA, Taleb S, Qotba H, Issa K, Abu Raddad LJ, Althani AA, Nasrallah GK, Yassine HM. Zedan HT, et al. Among authors: bernardini s. J Med Virol. 2024 Mar;96(3):e29527. doi: 10.1002/jmv.29527. J Med Virol. 2024. PMID: 38511514
Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499.
Guerrieri M, Francavilla B, Fiorelli D, Nuccetelli M, Passali FM, Coppeta L, Somma G, Bernardini S, Magrini A, Di Girolamo S. Guerrieri M, et al. Among authors: bernardini s. Vaccines (Basel). 2023 Jan 13;11(1):172. doi: 10.3390/vaccines11010172. Vaccines (Basel). 2023. PMID: 36680041 Free PMC article.
Urine Parameters in Patients with COVID-19 Infection.
Morello M, Amoroso D, Losacco F, Viscovo M, Pieri M, Bernardini S, Adorno G. Morello M, et al. Among authors: bernardini s. Life (Basel). 2023 Jul 28;13(8):1640. doi: 10.3390/life13081640. Life (Basel). 2023. PMID: 37629497 Free PMC article. Review.
575 results